Author:
Monini Paolo,Cafaro Aurelio,Srivastava Indresh K.,Moretti Sonia,Sharma Victoria A.,Andreini Claudia,Chiozzini Chiara,Ferrantelli Flavia,Cossut Maria R. Pavone.,Tripiciano Antonella,Nappi Filomena,Longo Olimpia,Bellino Stefania,Picconi Orietta,Fanales-Belasio Emanuele,Borsetti Alessandra,Toschi Elena,Schiavoni Ilaria,Bacigalupo Ilaria,Kan Elaine,Sernicola Leonardo,Maggiorella Maria T.,Montin Katy,Porcu Marco,Leone Patrizia,Leone Pasqualina,Collacchi Barbara,Palladino Clelia,Ridolfi Barbara,Falchi Mario,Macchia Iole,Ulmer Jeffrey B.,Buttò Stefano,Sgadari Cecilia,Magnani Mauro,Federico Maurizio P. M.,Titti Fausto,Banci Lucia,Dallocchio Franco,Rappuoli Rino,Ensoli Fabrizio,Barnett Susan W.,Garaci Enrico,Ensoli Barbara
Publisher
Public Library of Science (PLoS)
Reference83 articles.
1. Vaccination with ALVAC and AIDSVAX to prevent HIV-1 infection in Thailand. N Engl J Med;S Rerks-Ngarm,2009
2. Immune-correlates analysis of an HIV-1 vaccine efficacy trial. N Engl J Med;BF Haynes,2012
3. Cafaro A, Macchia I, Maggiorella MT, Titti F, Ensoli B (2009). Innovative approaches to develop prophylactic and therapeutic vaccines against HIV/AIDS. In: Pharmaceutical Biotechnology (Guzman C.A. and Fuerstein G. Eds.), Chapter No. 14, 189–242.
4. Control of SHIV-89.6P-infection of cynomolgus monkeys by HIV-1 Tat protein vaccine;A Cafaro;Nat Med,1999
5. SHIV89.6P pathogenicity in cynomolgus monkeys and control of viral replication and disease onset by human immunodeficiency virus type 1 Tat vaccine;A Cafaro;J Med Primatol,2000